WO2007099559A8 - Method of preparation for novel composition of 2-{(2,6 dichlorophenyl) amino] benzeneacetic acid carboxymethyl ester or 2-[2-[2-(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid and method of its use - Google Patents

Method of preparation for novel composition of 2-{(2,6 dichlorophenyl) amino] benzeneacetic acid carboxymethyl ester or 2-[2-[2-(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid and method of its use

Info

Publication number
WO2007099559A8
WO2007099559A8 PCT/IN2007/000078 IN2007000078W WO2007099559A8 WO 2007099559 A8 WO2007099559 A8 WO 2007099559A8 IN 2007000078 W IN2007000078 W IN 2007000078W WO 2007099559 A8 WO2007099559 A8 WO 2007099559A8
Authority
WO
WIPO (PCT)
Prior art keywords
dichlorophenyl
amino
acid
preparation
novel composition
Prior art date
Application number
PCT/IN2007/000078
Other languages
French (fr)
Other versions
WO2007099559A9 (en
WO2007099559A2 (en
Inventor
Dinesh Shantilal Patel
Sachin Dinesh Patel
Shashikant Prabhudas Kurani
Original Assignee
Dinesh Shantilal Patel
Sachin Dinesh Patel
Shashikant Prabhudas Kurani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dinesh Shantilal Patel, Sachin Dinesh Patel, Shashikant Prabhudas Kurani filed Critical Dinesh Shantilal Patel
Priority to BRPI0708386-6A priority Critical patent/BRPI0708386A2/en
Publication of WO2007099559A2 publication Critical patent/WO2007099559A2/en
Publication of WO2007099559A8 publication Critical patent/WO2007099559A8/en
Publication of WO2007099559A9 publication Critical patent/WO2007099559A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PCT/IN2007/000078 2006-03-01 2007-02-28 Method of preparation for novel composition of 2-{(2,6 dichlorophenyl) amino] benzeneacetic acid carboxymethyl ester or 2-[2-[2-(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid and method of its use WO2007099559A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0708386-6A BRPI0708386A2 (en) 2006-03-01 2007-02-28 Preparation method for modern stable composition including aceclofenac and 2,5-di-o-methyl-1,4: 3,6-dianhydro-d-glucitol as a solvent and method of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN295/MUM/2006 2006-03-01
IN295MU2006 2006-03-01

Publications (3)

Publication Number Publication Date
WO2007099559A2 WO2007099559A2 (en) 2007-09-07
WO2007099559A8 true WO2007099559A8 (en) 2008-05-08
WO2007099559A9 WO2007099559A9 (en) 2009-08-20

Family

ID=38459446

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000078 WO2007099559A2 (en) 2006-03-01 2007-02-28 Method of preparation for novel composition of 2-{(2,6 dichlorophenyl) amino] benzeneacetic acid carboxymethyl ester or 2-[2-[2-(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid and method of its use

Country Status (3)

Country Link
BR (1) BRPI0708386A2 (en)
RU (1) RU2008138475A (en)
WO (1) WO2007099559A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8734852B2 (en) * 2011-11-30 2014-05-27 Manu Chaudhary Parenteral controlled release formulations of NSAID's
WO2017210390A1 (en) * 2016-06-01 2017-12-07 St. Renatus, Llc Intranasal dental anesthetic
CA3108680A1 (en) * 2018-08-13 2020-02-20 AMEZCUA AMEZCUA, Federico Sinergic pharmaceutical composition of aceclofenac and betamethasone for the treatment of pain in localized forms of rheumatic conditions

Also Published As

Publication number Publication date
BRPI0708386A2 (en) 2011-05-24
RU2008138475A (en) 2010-04-10
WO2007099559A9 (en) 2009-08-20
WO2007099559A2 (en) 2007-09-07

Similar Documents

Publication Publication Date Title
IL212033A (en) Modified release pharmaceutical composition comprising (r)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl] acetic acid anilide and a process for producing the same
WO2008047229A3 (en) Biaryl ether urea compounds
EP2119373A4 (en) Sweet-type seasoning compositions containing high proportion of amino acid and yeast for obtaining the same
WO2006114415A3 (en) Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester
WO2007056517A3 (en) Pharmaceutical salts and polymorphs of n- (5-chl0r0-2-pyridinyl) -2- [ [4- [ (dimethylamino) iminomethyl] benzoyl] amino] -5-meth oxy-benzamide, a factor xa inhibitor
WO2011141933A3 (en) Process for preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid and its pharmaceutically acceptable salts
IL185244A0 (en) 1-sulfonyl-piperidine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus
WO2007143113A3 (en) The use of enzymatic resolution for the preparation of intermediates of pregabalin
WO2007139933A3 (en) Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
SI1937065T1 (en) Novel lysine salts of 4-((phenoxyalkyl) thio)-phenoxyacetic acid derivatives
WO2008157635A3 (en) Synthetic bile acid composition, method, and preparation
WO2008068615A8 (en) Crystalline forms of ( 3 s ) -3- [n- (n' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' -tetrafluoro phenoxy) -4-0x0penta noic acid
WO2009141718A3 (en) Process for the preparation of prostaglandin analogues and intermediates thereof
WO2008053297A3 (en) Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
IL223126A (en) Method for the preparation of acetic acid 4,5-diacetoxy-tetrahydro-furan-2-ylmethyl ester and its stereoisomers
IL190880A (en) Crystalline fusidic acid, method for its preparation and pharmaceutical composition comprising it
IL188438A (en) Pharmacologically active benzofused five-membered heterocycles, or pharmaceutically acceptable salts and esters thereof and pharmaceutical compositions containing them and their use as inhibitors of catechol-o-methyltransferase (comt) enzyme
IL184885A0 (en) 7-{4-[2-(2,6-dihydro-4-methylphenoxy)ethoxyl]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-s-carboxylic acid cyclopropyl-(2,3-dimethylbenzyd amide as inhibitors of renin for the treatment of hypertension
IL195473A (en) Piperazine acetic acid derivatives as glycine transporter-1 inhibitors, process of preparation thereof, pharmaceutical compositions comprising them, use thereof in the preparation of pharmaceutical compositions and intermediates for their preparation
WO2008001391A3 (en) Site-specific inhibitors of histone methyltransferase [hmtase] and process of preparation thereof
WO2008117305A3 (en) A novel process for preparing pregabalin and its acid addition salts
EG25838A (en) Process for the preparation of amino acid methyl esters
EP1883619B8 (en) Process of preparation of substituted tetrafluorobenzylaniline compound and its pharmaceutically approved salts
WO2007099559A9 (en) Method of preparation for novel composition of 2-{(2,6 dichlorophenyl) amino] benzeneacetic acid carboxymethyl ester or 2-[2-[2-(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid and method of its use
WO2009154785A3 (en) C4-substituted alpha-keto oxazoles

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

ENP Entry into the national phase in:

Ref document number: 2008138475

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12225291

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 07736539

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase in:

Ref document number: PI0708386

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080828